Invention Grant
- Patent Title: Nucleic acid molecules which encode human anti-CD20 antibodies and methods of use thereof
- Patent Title (中): 编码人抗CD20抗体的核酸分子及其使用方法
-
Application No.: US12965956Application Date: 2010-12-13
-
Publication No.: US08097713B2Publication Date: 2012-01-17
- Inventor: Joel H. Martin , Li-Hsien Wang , Sean Stevens , Erin M. Allison
- Applicant: Joel H. Martin , Li-Hsien Wang , Sean Stevens , Erin M. Allison
- Applicant Address: US NY Tarrytown
- Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee Address: US NY Tarrytown
- Agent Valeta Gregg; Frank R. Cottingham
- Main IPC: C12N15/13
- IPC: C12N15/13 ; C12N15/63 ; C12P21/08

Abstract:
The present invention provides nucleic acid molecules which encode human antibodies or antigen-binding fragments thereof that specifically bind human CD20. Also provided are expression vectors comprising nucleic acid molecules that encode anti-CD20 antibodies, and methods of producing anti-human CD20 antibodies or antigen-binding fragments thereof.
Public/Granted literature
- US20110081681A1 HUMAN ANTIBODIES TO HUMAN CD20 AND METHOD OF USING THEREOF Public/Granted day:2011-04-07
Information query
IPC分类: